These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2688754)

  • 1. Chronic lymphocytic leukaemia: when and how to treat.
    Rozman C; Montserrat E
    Blut; 1989 Dec; 59(6):467-74. PubMed ID: 2688754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current approaches to the treatment and management of chronic lymphocytic leukaemia.
    Montserrat E; Rozman C
    Drugs; 1994; 47 Suppl 6():1-9. PubMed ID: 7525184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukaemia (CLL): treatment.
    Rozman C; Montserrat E
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():159-61. PubMed ID: 2469508
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
    Molica S; De Rossi G; Luciani M; Levato D
    Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of chronic lymphocytic leukemia.
    Han T; Rai KR
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):431-45. PubMed ID: 2182600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of chronic lymphocytic leukaemia.
    Kalil N; Cheson BD
    Drugs Aging; 2000 Jan; 16(1):9-27. PubMed ID: 10733261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key issues in the treatment of chronic lymphocytic leukaemia (CLL).
    Catovsky D; Murphy RL
    Eur J Cancer; 1995 Dec; 31A(13-14):2146-54. PubMed ID: 8652233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
    International CLL-IPI working group
    Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple myeloma and chronic lymphocytic leukemia].
    Labardini-Méndez J; Alexanian R; Barlogie B
    Rev Invest Clin; 1997 May; 49 Suppl 1():28-33. PubMed ID: 9380986
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of the efficacy of ofatumumab in patients with chronic lymphocytic leukaemia treated in the Department of Haematooncology and Bone Marrow Transplantation of the Medical University in Lublin - Prelimary results.
    Wąsik-Szczepanek E; Szymczyk A; Kowal M; Nogalski A; Hus M
    Ann Agric Environ Med; 2018 Mar; 25(1):56-59. PubMed ID: 29575875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in chronic lymphocytic leukemia. International Workshop on chronic Lymphocytic Leukemia.
    Gale RP; Caligaris-Cappio F; Dighiero G; Keating M; Montserrat E; Rai K
    Leukemia; 1994 Sep; 8(9):1610-4. PubMed ID: 7522296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukaemia treatment.
    Montserrat E; Rozman C
    Blood Rev; 1993 Sep; 7(3):164-75. PubMed ID: 8241831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic lymphatic leukemia].
    Hinterberger W
    Wien Med Wochenschr; 1991; 141(9-10):198-201. PubMed ID: 1949842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of stage A chronic lymphocytic leukaemia untreated patients. French Cooperative Group on Chronic Lymphocytic Leukaemia.
    Br J Haematol; 1990 Sep; 76(1):45-57. PubMed ID: 2223648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing and treating chronic lymphocytic leukemia in 2009.
    Kaufman M; Rubin J; Rai K
    Oncology (Williston Park); 2009 Nov; 23(12):1030-7. PubMed ID: 20017285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative strategies for the treatment of CLL.
    Keating M; Cheson B; Gribben JG; Robertson B; Nadler L
    Leuk Lymphoma; 1996 Oct; 22 Suppl 2():53-64. PubMed ID: 9021709
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing Oncologist.
    Pinilla-Ibarz J; Emole J
    Cancer Control; 2015 Oct; 22(4 Suppl):7-16. PubMed ID: 26618341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
    Stilgenbauer S; Eichhorst B; Schetelig J; Coutre S; Seymour JF; Munir T; Puvvada SD; Wendtner CM; Roberts AW; Jurczak W; Mulligan SP; Böttcher S; Mobasher M; Zhu M; Desai M; Chyla B; Verdugo M; Enschede SH; Cerri E; Humerickhouse R; Gordon G; Hallek M; Wierda WG
    Lancet Oncol; 2016 Jun; 17(6):768-778. PubMed ID: 27178240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An old and simple solution for a new problem--more on clinical staging and evaluation of response in B-cell chronic lymphocytic leukaemia in the era of new therapies.
    Jaksic O; Vitale B; Jaksic B
    Br J Haematol; 2014 Jun; 165(5):737-40. PubMed ID: 24611532
    [No Abstract]   [Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation in chronic lymphocytic leukemia.
    Rosner F
    Ann Intern Med; 1996 Nov; 125(9):780. PubMed ID: 8929022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.